SRZN as of Nov 1 · 08:19 ET
SRZNNasdaqBiological Products, (No Diagnostic Substances)

Surrozen, Inc. · Brief

Next report

No upcoming report date.

Expected move

No implied move.

Implied vs realized

2 reportsHistory
—≥ implied
Q2 FY26—▲+18.39%—
Oct 20 '26±19.1%▲+0.72%×0.04
quarterimplied−20%0+20%realized×
Oct '26±19.1%▲+0.72%×0.04
Q2 FY26—▲+18.39%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Bull2 of 3

+22.81%change in shares held by largest reporting managers over the latest quarter13F · Jun 30 '26
70managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

15managers holding a concentrated share of reported value13F · Jun 30 '26
4 of 24largest reporting managers reduced their stake in the latest quarter13F · Jun 30 '26
AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

SRZN report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 20impliedImplied move: ±19.1% into Oct 20 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.